HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Other Private Labelers Likely NBTY Suitors – Market Analyst

This article was originally published in The Tan Sheet

Executive Summary

Nutritional supplement manufacturer and marketer NBTY would be attractive to other private-label firms outside as well as within the supplement arena, but not to over-the-counter drug firms looking to expand into the field, according to an industry analyst

You may also be interested in...



NBTY Sees Double Digit Q1 Sales Growth; Efficiencies Drive Bump In Profits

Nutritional supplement manufacturer and marketer NBTY says a "mix of better selling products" gained "improved product placement" in U.S. markets as its Wholesale/U.S. Nutrition unit's 2007 first-quarter (ended Dec. 31) sales increased $22 million from the year-ago period to $247 million

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS138352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel